Product Information

METHYLPREDNISOLONE 8 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.9178 per EA under NDC 68382091711. Its NADAC has been published 425 times since Oct 3, 2018.

FDA first approved this application on Apr 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPREDNISOLONE 8 MG TABLET

methylprednisolone
$0.9178per EA

Strength

8 mg/1

NDC

68382091711

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHYLPREDNISOLONE

Approval Type

Generic (ANDA)

FDA Application

ANDA206751

FDA Approved

4/23/2018

TE Code

AB

On Market Since

5/1/2018

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for METHYLPREDNISOLONE 8 MG TABLET has been published 425 times since Oct 3, 2018, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9178 per EA
All-time high$1.4125 (Nov 13, 2019)
All-time low$0.7954 (May 22, 2024)
52-week high$1.0323
52-week low$0.9149
Median price$1.1300
Average price$1.1193
Largest weekly change+42.4% (Dec 20, 2023)
Weeks tracked425
Tracking sinceOct 3, 2018

Price History

1W

-0.6%

1M

-1.6%

3M

+0.3%

6M

-11.1%

1Y

-9.1%

3Y

-18.8%

5Y

-20.9%

All

-23.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPREDNISOLONE 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 8 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.9178 per EA (NDC 68382091711), effective Nov 18, 2026.

How has the price of METHYLPREDNISOLONE 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has declined 23.9%. It has been tracked across 425 weekly CMS publications since Oct 3, 2018.

What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 8 MG TABLET?

Since Oct 3, 2018, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has ranged from a low of $0.7954 (May 22, 2024) to a high of $1.4125 (Nov 13, 2019), with a median of $1.1300 per EA.

Are there cheaper alternatives to METHYLPREDNISOLONE 8 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPREDNISOLONE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPREDNISOLONE 8 MG TABLET?

METHYLPREDNISOLONE 8 MG TABLET (NDC 68382091711) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.